newsfilter
← Latest News
GlobeNewswire·

Nkarta to Participate in Needham Virtual Healthcare Conference

  • Nkarta, Inc. (NASDAQ: NKTX) announced its participation in the 25th Annual Needham Virtual Healthcare Conference.
  • CEO Paul Hastings will join a virtual panel titled "Cell Therapy in Autoimmune: State of the Art and What Comes Next" at 11:45 a.m. ET on Wednesday, April 15.
  • President Nadir Mahmood will lead a fireside chat at 3:45 p.m. ET on the same day to share updates on the company's investigational CAR-NK cell therapy for B cell-mediated autoimmune diseases.
  • A simultaneous webcast of the fireside chat will be available on the Investors section of Nkarta's website with a replay archived for approximately 90 days.
  • Nkarta is a clinical-stage biotechnology company developing allogeneic, off-the-shelf natural killer cell therapies engineered for deep therapeutic activity & broad outpatient access.